"Plasmapheresis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.
| Descriptor ID |
D010956
|
| MeSH Number(s) |
E02.120.770 E02.912.715
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Plasmapheresis".
Below are MeSH descriptors whose meaning is more specific than "Plasmapheresis".
This graph shows the total number of publications written about "Plasmapheresis" by people in this website by year, and whether "Plasmapheresis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Plasmapheresis" by people in Profiles.
-
Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol. 2011 Sep; 7(9):507-17.
-
Holguin F, Ramadan B, Gal AA, Roman J. Prognostic factors for hospital mortality and ICU admission in patients with ANCA-related pulmonary vasculitis. Am J Med Sci. 2008 Oct; 336(4):321-6.
-
Kayler LK, Farber JL, Colombe B, LaCava D, Friedewald JJ, Ratner LE. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation. Transpl Int. 2006 Feb; 19(2):128-39.
-
Segev DL, Simpkins CE, Warren DS, King KE, Shirey RS, Maley WR, Melancon JK, Cooper M, Kozlowski T, Montgomery RA. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant. 2005 Oct; 5(10):2570-5.
-
Venkateshiah SB, Thomassen MJ, Kavuru MS. Pulmonary alveolar proteinosis. Clinical manifestations and optimal treatment strategies. Treat Respir Med. 2004; 3(4):217-27.
-
Kavuru MS, Bonfield TL, Thomassen MJ. Plasmapheresis, GM-CSF, and alveolar proteinosis. Am J Respir Crit Care Med. 2003 Apr 1; 167(7):1036; author reply 1036-7.
-
Bonfield TL, Kavuru MS, Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol. 2002 Dec; 105(3):342-50.
-
Dalakas MC, Cupler EJ. Neuropathies in HIV infection. Baillieres Clin Neurol. 1996 Mar; 5(1):199-218.
-
Dalakas MC. Current treatment of the inflammatory myopathies. Curr Opin Rheumatol. 1994 Nov; 6(6):595-601.
-
La Rocca RV, Meer J, Gilliatt RW, Stein CA, Cassidy J, Myers CE, Dalakas MC. Suramin-induced polyneuropathy. Neurology. 1990 Jun; 40(6):954-60.